The world’s first and only, animal-free, commercially available recombinant human albumin, approved for use in the manufacture of human therapeutics.
Used in the manufacture of the FDA and EMEA approved M-M-R™ II childhood vaccine from Merck and Co., Recombumin* is also being evaluated as an excipient, or ingredient, in several other products undergoing clinical development in the US and EU.
Key benefits
- Stabilize your product in liquid formulation at room temperature
- Improve visual appearance of lyophilized product and decrease dissolution time
- Manufactured to Q7 GMP in FDA, Health Canada and MHRA inspected facilities
- Extend product bioavailability
- Half-life extension of peptides.
No comments:
Post a Comment